Next Article in Journal
Functional Evaluation and Nephrotoxicity Assessment of Human Renal Proximal Tubule Cells on a Chip
Next Article in Special Issue
Upconversion Fluorescence Nanoprobe-Based FRET for the Sensitive Determination of Shigella
Previous Article in Journal
Rational Construction of a Mitochondria-Targeted Reversible Fluorescent Probe with Intramolecular FRET for Ratiometric Monitoring Sulfur Dioxide and Formaldehyde
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Metal and pH-Dependent Aptamer Binding of Tetracyclines Enabling Highly Sensitive Fluorescence Sensing

Department of Chemistry, Waterloo Institute for Nanotechnology, Water Institute, University of Waterloo, Waterloo, ON N2L 3G1, Canada
*
Author to whom correspondence should be addressed.
Biosensors 2022, 12(9), 717; https://doi.org/10.3390/bios12090717
Submission received: 29 July 2022 / Revised: 28 August 2022 / Accepted: 30 August 2022 / Published: 3 September 2022
(This article belongs to the Special Issue Optical Biosensors for Health, Food and Environment (Bio)markers)

Abstract

:
Tetracyclines are a widely used group of antibiotics, many of which are currently only used in veterinary medicine and animal husbandry due to their adverse side effects. For the detection of tetracyclines, we previously reported a DNA aptamer named OTC5 that binds to tetracycline, oxytetracycline, and doxycycline with similar KD’s of ~100 nM. Tetracyclines have an intrinsic fluorescence that is enhanced upon binding to OTC5, which can be used as a label-free and dye-free sensor. In this work, the effect of pH and metal ions on the sensor was studied. Mg2+ ions are required for the binding of OTC5 to its target with an optimal concentration of 2 mM. Other metal ions including Ca2+ and Zn2+ can also support aptamer binding. Although Mn2+ barely supported binding, the binding can be rescued by Mg2+. ITC studies confirmed that OTC5 had a KD of 0.2 μM at a pH of 6.0 and 0.03 μM at a pH of 8.3. Lower pH (pH 6) showed better fluorescence enhancement than higher pH (pH 8.3), although a pH of 6.0 had slightly higher KD values. Under optimized sensing conditions, sensors with limit of detections (LODs) of 0.1–0.7 nM were achieved for tetracycline, oxytetracycline, and doxycycline, which are up to 50-fold lower than previously reported. Milk samples were also tested yielding an LOD of 16 nM oxytetracycline at a pH of 6.0.

1. Introduction

Tetracyclines refer to a class of broad-spectrum antibiotics with a linearly fused four ring structure that inhibit bacterial protein synthesis by blocking the aminoacyl-tRNA attachment to ribosomes [1]. Chlortetracycline (CTC, market name Aureomycin) and oxytetracycline (OTC, market name Terramycin) were among the first tetracyclines approved for clinical use in the late 1940s [2]. Due to their toxicity, CTC, OTC, and tetracycline (TC) are currently used mostly in animal husbandry and veterinary medicine, although some are still used on humans [3]. Traces of these tetracyclines can be found in animal tissues or excreted into waterways to contaminate the environment [4]. Another highly popular tetracycline antibiotic is doxycycline (DOX), which has a longer half-life in the body and better absorption [5]. OTC, TC, and DOX have very similar structures.
Traditionally, the detection of tetracycline antibiotics was performed with chromatography or immunoassays. High-performance liquid chromatography (HPLC) was used to detect tetracyclines with good sensitivity but required extensive pre-treatment of samples [6]. Immunoassays, such as ELISA, have shown similar sensitivity to HPLC but are both cheaper and require less pre-treatment of samples [7]. Nanomaterials have also been developed to enhance detection [8,9,10]. In addition, the use of aptamers and aptasensors have gained popularity [11,12].
Aptamers are single-stranded oligonucleotides that are ideal for the detection of small molecules [13,14,15]. Advantages of aptamers include being amenable to in vitro selection, good selectivity, and good specificity. They can be combined with existing technologies such as fluorescence spectroscopy, electrochemistry, and nanomaterials to create new and improved sensing platforms [16]. Compared to antibodies, DNA aptamers are much more stable, cost-effective, and easier to modify. Recently, many new and high-quality DNA aptamers for various small molecules have been reported [17,18,19,20,21,22].
We recently reported a DNA aptamer named OTC5 that was isolated using the capture-SELEX method with OTC as a target molecule [23]. OTC5 has a high affinity to OTC, TC, and DOX with KD around 100 nM. The tetracyclines are fluorescent with a large Stokes shift in water [24]. An interesting feature of the OTC5 aptamer is that it can enhance the fluorescence of the tetracyclines, which not only provides a method for detection, but also a convenient and robust way for measuring aptamer binding [25]. While other aptamers for tetracyclines have been reported before [26,27,28,29], we were the first to take advantage of the intrinsic fluorescence of tetracyclines for detection.
Tetracyclines have a number of pKa values and changing pH can influence the charge of the molecule. In the previous work, we performed most of the binding assays in the selection buffer, which had a pH of 7.8. This pH is close to the pKa2 of the antibiotics and thus, they were a mixture of protonated and deprotonated forms. To test the effect of pH on aptamer binding and fluorescence enhancement, we herein systematically varied the pH to be either below or above the pKa2. At a pH of 6.0, the tetracyclines are charge neutral, whereas at a pH of 8.3, they carry one negative charge. Thus, these two pH values were studied.
In addition, tetracyclines are known to bind to divalent metal ions [30,31,32], which may also affect their fluorescence [33]. Metal ions can also affect aptamer binding [34,35]. Thus, the effect of metal ions coupled with the change of pH needs to be studied to characterize aptamer binding and related biosensors. In this work, we systematically studied the effect of pH and metal ions on the sensing of the tetracyclines by the OTC5 aptamer. At a pH of 6.0 with Mg2+, up to 20-fold fluorescence enhancement was achieved, allowing highly sensitive detection down to sub-nanomolar levels.

2. Materials and Methods

2.1. Chemicals

All of the DNA oligonucleotides were purchased from Integrated DNA Technologies (Coralville, IA, USA). TC, OTC, DOX, and other chemicals were from Sigma-Aldrich. Milli-Q water was used to prepare all the buffers and solutions.

2.2. Fluorescence Spectroscopy

The experiments were performed on a Tecan Spark microplate reader with excitation wavelength set at 370 nm and emission at 530 nm. For most titrations, 100 nM OTC, TC, or DOX was dissolved in buffer (10 mM MES, pH 6.0 or 10 mM Tris HCl, pH 8.3, 50 mM NaCl, 0 or 2 mM MgCl2). The OTC5 aptamer was titrated such that the final volume change was kept to be less than 10%. The solution was well-mixed after each titration and allowed to equilibrate for 1 min before reading. Similar methods were used for the measurement of OTC-dependent fluorescence with 0 or 2 µM OTC5 aptamer.

2.3. Isothermal Titration Calorimetry

Isothermal titration calorimetry (ITC) was performed using a MicroCal VP-ITC. An amount of 150 μM of oxytetracycline was titrated into 9 μM OTC5 aptamer. The oxytetracycline and OTC5 aptamer were diluted using the same buffer for the desired pH. At pH 6.0, 10 mM MES buffer with 2 mM Mg2+ was used. At pH 8.3, 10 mM Tris buffer with 2 mM Mg2+ was used. Background heat of titrating antibiotics into each buffer was subtracted. Data analysis was performed using the accompanying Origin software.

2.4. Milk Extraction and Detection

Milk (2% fat) was purchased from a local supermarket. Six 1.2-milileter milk samples were first spiked with different concentrations of OTC. To extract OTC, 30 μL HCl (1 M) were added to each milk sample, and the samples were centrifuged at 15,000 rpm (17,530× g) for 15 min. The supernatants were then removed and diluted 100-fold in MES (pH 6.0) buffer containing 2 mM Mg2+. An amount of 98 μL of this solution was then added to each well in a 96-well plate. Two blanks of buffer were also added to the plate. The base fluorescence was read using the Tecan microplate reader. Then, 2 μL of the 100 μM OTC5 aptamer (in water) were added for a final concentration of 2 μM OTC5, and the fluorescence was immediately read.

3. Results and Discussion

3.1. The Tetracyclines and the OTC5 Aptamer

The structures of OTC, TC, and DOX and their pKa values are shown in Figure 1A. At a pH of 6.0, all three antibiotics are nearly charge neutral, whereas at a pH of 8.3, the majority of them are negatively charged (Figure 1B). The secondary structure of the OTC5 aptamer is shown in Figure 1C, which has a similar affinity for binding to these three antibiotics [23]. The majority of our previous studies was performed at a pH of 7.8, which was used for the selection of the OTC5 aptamer. Here, we studied both a pH of 6.0 and a pH of 8.3 to understand the effect of pH.
Based on the aptamer-binding-induced fluorescence enhancement of the tetracyclines, we previously developed a label-free and dye-free sensing method, as described in Figure 1D [23]. When the OTC5 aptamer was added, only the tetracyclines became fluorescent, whereas other molecules, even fluorophores, had no fluorescence change. The aptamer-binding-induced fluorescence enhancement is likely due to the more hydrophobic environment provided by the aptamer binding pocket to slow down non-radiative relaxation pathways. To achieve better sensitivity, it is desirable to have a low background fluorescence and a large fluorescence enhancement upon aptamer binding.

3.2. pH- and Mg2+-Dependent Fluorescence of the Tetracyclines

We first measured the intrinsic fluorescence of the three tetracyclines as a function of Mg2+ concentration at two pH (Figure 2). They all had lower fluorescence at a pH of 6.0 than at a pH of 8.3. Thus, protonation of them lowered the quantum yield. At both pH levels, adding Mg2+ increased their fluorescence, and the fluorescence enhancement was higher at a pH of 8.3. If we fit a binding curve to these data points, the KD for Mg2+ was below 0.5 mM at a pH of 8.3, whereas the KD was higher than 5 mM at a pH of 6.0. At a pH of 6.0, the pKa2 position is protonated. It is likely that this position is involved in binding Mg2+ since its protonation decreased Mg2+ binding. These antibiotics are known to chelate divalent metal ions and such binding can enhance their fluorescence [33]. Therefore, when testing the effect of the OTC5 aptamer, we need to study the effect of pH and Mg2+.
For the detection of the tetracyclines using the method in Figure 1D, having a lower background fluorescence in the absence of the OTC5 aptamer is advantageous. To find the optimal Mg2+ concentration, we then compared the fluorescence of the samples in the absence and presence of 2 µM OTC5 aptamer, and the highest fluorescence increase occurred at above 0.5 mM Mg2+ (Figure S1). When the Mg2+ concentration was higher than 5 mM, the fluorescence enhancement also decreased. Thus, we picked 2 mM Mg2+ for our subsequent studies.

3.3. pH- and Mg2+-Dependent Aptamer Binding

We then tested the fluorescence change of OTC with the addition of the OTC5 aptamer. At a pH of 6.0, the background fluorescence of 100 nM OTC was quite low, but with the addition of 2 µM OTC5 aptamer, a large enhancement was achieved (Figure 3A). We then systematically tested the response over a broad pH range from 4 to 8 (Figure 3B). Although a pH of 5 showed the highest fold of fluorescence enhancement, a pH of 6 gave higher fluorescence intensities. In addition, TC and OTC are less stable at acidic pH [37]. Therefore, we chose a pH of 6 as our acidic pH for subsequent studies.
We then measured the OTC5 aptamer binding to 100 nM DOX at a pH of 6.0. By gradually titrating the aptamer, over 20-fold fluorescence enhancement was achieved with 3.7 µM aptamer added (Figure 4A, red line), which was much higher than that observed previously at a pH of 7.8 (only around 2-fold). The KD was fitted to be 0.39 µM. Without Mg2+, the fluorescence barely changed, indicating a lack of binding. Therefore, this aptamer requires Mg2+ for target binding.
We then repeated this experiment at a pH of 8.3 (Figure 4B). In this case, for the sample with 2 mM Mg2+ added, the background fluorescence was higher and the final fluorescence was lower. The fluorescence enhancement was only 4-fold, although the KD was slightly smaller (0.24 µM). Still, when no Mg2+ was added, the binding was lost and the fluorescence barely changed upon titration of the OTC5 aptamer. The same experiments were also performed for OTC (Figure 4C,D) and TC (Figure 4E,F), and the conclusions were the same. For OTC, at a pH of 6.3, the KD for the aptamer was 0.14 µM, slightly higher than that at a pH of 8.3 (0.06 µM), but the fluorescence enhancement upon aptamer binding was much higher. For TC, at a pH of 6.3, the KD for the aptamer was 0.36 µM, about 1-fold higher than that at a pH of 8.3 (0.16 µM).
Therefore, to use the aptamer-binding-induced fluorescence for the detection of these antibiotics, a pH of 6.0 appeared to be a better condition due to its much higher fluorescence enhancement. In all of the cases, Mg2+ was required for aptamer binding.

3.4. Aptamer Binding Assay Using ITC

To further characterize the binding of the aptamers at different pH, isothermal titration calorimetry (ITC) was performed. OTC was titrated into the OTC5 aptamer at a pH of 6.0 (Figure 5A) and a pH of 8.3 (Figure 5B). The downward spikes indicated an exothermic reaction. By integrating the heat, the KD at a pH of 6.0 was fitted to be 0.20 μM, whereas the KD at a pH of 8.3 was nearly seven times lower at 0.03 μM (Table 1). By comparing the KD’s at a pH of 6.0 and 8.3 to the previously reported KD at a pH of 7.8 (0.15 μM) [23], it confirmed stronger binding affinities at higher pH levels.

3.5. Effect of other Metal Ions

After determining the importance of Mg2+ for aptamer binding, we then studied the effect of some other divalent metal ions. Since the behavior of these antibiotics were similar, we focused on OTC. We first replaced Mg2+ with Ca2+ (Figure 6A). Ca2+ can also enhance the fluorescence of OTC, indicating binding. The addition of OTC5 aptamer also enhanced the fluorescence enhancement, although the change was smaller compared to the samples with Mg2+. When we tested Mn2+, the fluorescence of OTC dropped with an increasing concentration of Mn2+ (Figure 6B). Although fluorescence was enhanced with the addition of the OTC5 aptamer, the increase was quite modest (less than 1-fold). With Zn2+, the fluorescence enhancement was higher and adding OTC5 induced a significant increase (Figure 6C). Overall, the sensor would work the best in the presence of Mg2+.
This could be related to the selection condition, where 10 mM Mg2+ was used [23]. Since the tetracyclines can bind to various metal ions [6,27,38], we reason that Mg2+ must be involved in bridging OTC and the aptamer instead of acting as a general salt to screen charge repulsion. Zn2+ and Ca2+ can partially replace the role of Mg2+ and support aptamer binding. Since the least fluorescence change by adding the OTC5 aptamer was seen with Mn2+, we then tested whether we can rescue the sensor performance by adding extra Mg2+. We performed the aptamer titration with 0.5 mM Mn2+ alone and with an additional 2 mM Mg2+ (Figure S2). With the extra Mg2+, 5-fold fluorescence enhancement was achieved and the overall fluorescence was also much higher. Therefore, adding extra Mg2+ can be a useful method for samples with unknown metal compositions.

3.6. Label-Free and Dye-Free Sensing of Tetracyclines

The above studies have also optimized the conditions to achieve better sensitivity. We then tested the sensitivity of the sensors using the method described in Figure 1D. For each analyte concentration, two measurements were performed: before and after adding 2 µM OTC5 aptamer. We chose to use 2 µM aptamer since saturated binding can be achieved at this condition, as shown in Figure 4. For all three antibiotics, we observed linear responses up to 1 µM (Figure 7A–C), and the slopes of the samples with the OTC5 aptamer were much higher. We then calculated the fluorescence difference of the two lines and plotted them in Figure 7D–F, which are the calibration curves for the tetracyclines. Based on the curves, we calculated the limit of detection (LOD) to be 0.7 nM, 0.5 nM, and 0.1 nM for DOX, OTC, and TC, respectively (3σ/slope where σ is the background variation). For comparison, in our previous condition, the LOD for OTC was 25 nM [23], and our new condition allowed a 50-fold improvement. Note that this detection method does not involve any covalent fluorophore labels or DNA staining dyes, and we solely relied on the intrinsic fluorescence of the tetracyclines.
We then tested the selectivity of the sensors against a series of different antibiotics (streptomycin, penicillin, ampicillin, chloramphenicol, and kanamycin). These antibiotics are not fluorescent at either a pH of 6.0 or 8.3, and their signals are close to zero (Figure 8A,B). OTC, DOX, and TC did show significant fluorescence increases. From highest to lowest, the fluorescence enhancement ranked TC > OTC > DOX and pH 6.0 > pH 8.3 (Figure 8C).

3.7. Detection in Milk

Finally, we tested this sensor using milk samples. Milk (2% fat) was spiked with various concentrations of OTC. Since tetracyclines are known to bind to proteins in milk, samples were first treated with HCl, centrifuged, then diluted in buffer before detection. In the treated milk, the sensor showed slightly better performance at a pH of 6.0 (Figure 9A). The LOD was calculated to be 16 nM at a pH of 6.0 (Figure 9B). This value is ~4 times lower than the LOD of 66 nM we previously reported at a pH of 7.8. We believe some of the OTC was degraded during the acid treatment [37], which may contribute to the much higher LOD value here compared to that in the buffer.

4. Conclusions

In this work, we investigated the pH and metal ion dependency of the OTC5 aptamer and its relevance in the fluorescent detection of three tetracycline antibiotics. The sensing performance of the OTC5 aptamer was studied at a pH of 6.0 and a pH of 8.3, at which the antibiotics were in charge neutral and negative charged states, respectively. In addition, the effect of a few common divalent metal ions was studied. When compared to other metal ions (Mn2+, Zn2+, and Ca2+), Mg2+ showed the best fluorescence increase and is required for OTC5 to bind. The optimal concentration of Mg2+ was around 2 mM. At a pH of 6.0, fluorescence enhancement upon binding OTC5 was shown to be greater than at a pH of 8.3 but had a higher KD. ITC experiments confirmed this by obtaining fitted KD values of 0.2 μM and 0.03 μM at a pH of 6.0 and a pH of 8.3, respectively. Optimized sensors for TC, OTC, and DOX were tested at a pH of 6.0 with 2 mM Mg2+. LODs of 0.1, 0.5, and 0.7 nM were achieved, which are ~50-fold lower than previously reported. This sensor detects TC, OTC, and DOX as a group and cannot tell their difference. Other aptamers with differential binding affinities to the antibiotics are needed to detect them individually. Milk samples were tested at a pH of 6.0, and the extracted milk samples showed LODs of 16 nM. Under our optimized conditions, over 10-fold fluorescence enhancement can be readily achieved, allowing this system to be coupled with various materials for developing interesting future biosensing applications [39,40].

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/bios12090717/s1, Figure S1: the effect of OTC5 aptamer as a function of Mg2+ concentration. Figure S2: rescue the sensor performance with Mn2+ by adding extra Mg2+.

Author Contributions

Conceptualization, J.L. (Juewen Liu) and Y.Z.; methodology, J.L. (Juewen Liu) and Y.Z.; investigation, Y.Z., B.G., P.S. and J.L. (Jiawen Liu) data curation, Y.Z., B.G., P.S. and J.L. (Jiawen Liu); writing—original draft preparation, Y.Z. and J.L. (Juewen Liu); writing—review and editing, Y.Z. and J.L. (Juewen Liu); supervision, J.L. (Juewen Liu); funding acquisition, J.L. (Juewen Liu). All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the Natural Sciences and Engineering Research Council of Canada (NSERC) and a Strathclyde/Waterloo Joint Transatlantic Funding.

Data Availability Statement

Not applicable.

Conflicts of Interest

The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; in the decision to publish the results.

References

  1. Chopra, I.; Roberts, M. Tetracycline Antibiotics: Mode of Action, Applications, Molecular Biology, and Epidemiology of Bacterial Resistance. Microbiol. Mol. Biol. Rev. 2001, 65, 232–260. [Google Scholar] [CrossRef] [PubMed]
  2. Grossman, T.H. Tetracycline Antibiotics and Resistance. Cold Spring Harb. Perspect. Med. 2016, 6, a025387. [Google Scholar] [CrossRef] [PubMed]
  3. Daghrir, R.; Drogui, P. Tetracycline Antibiotics in the Environment: A Review. Environ. Chem. Lett. 2013, 11, 209–227. [Google Scholar] [CrossRef]
  4. Xu, L.; Zhang, H.; Xiong, P.; Zhu, Q.; Liao, C.; Jiang, G. Occurrence, Fate, and Risk Assessment of Typical Tetracycline Antibiotics in the Aquatic Environment: A Review. Sci. Total Environ. 2021, 753, 141975. [Google Scholar] [CrossRef]
  5. Smith, K.; Leyden, J.J. Safety of Doxycycline and Minocycline: A Systematic Review. Clin. Ther. 2005, 27, 1329–1342. [Google Scholar] [CrossRef]
  6. Scaria, J.; Anupama, K.V.; Nidheesh, P.V. Tetracyclines in the Environment: An Overview on the Occurrence, Fate, Toxicity, Detection, Removal Methods, and Sludge Management. Sci. Total Environ. 2021, 771, 145291. [Google Scholar] [CrossRef]
  7. Himmelsbach, M.; Buchberger, W. Residue Analysis of Oxytetracycline in Water and Sediment Samples by High-Performance Liquid Chromatography and Immunochemical Techniques. Microchim. Acta 2005, 151, 67–72. [Google Scholar] [CrossRef]
  8. Tao, X.; Peng, Y.; Liu, J. Nanomaterial-Based Fluorescent Biosensors for Veterinary Drug Detection in Foods. J. Food Drug Anal. 2020, 28, 575–594. [Google Scholar] [CrossRef]
  9. Gao, W.; Li, P.; Qin, S.; Huang, Z.; Cao, Y.; Liu, X. A Highly Sensitive Tetracycline Sensor Based on a Combination of Magnetic Molecularly Imprinted Polymer Nanoparticles and Surface Plasmon Resonance Detection. Microchim. Acta 2019, 186, 637. [Google Scholar] [CrossRef]
  10. Wang, C.-Y.; Wang, C.-C.; Zhang, X.-W.; Ren, X.-Y.; Yu, B.; Wang, P.; Zhao, Z.-X.; Fu, H. A New Eu-Mof for Ratiometrically Fluorescent Detection toward Quinolone Antibiotics and Selective Detection toward Tetracycline Antibiotics. Chin. Chem. Lett. 2022, 33, 1353–1357. [Google Scholar] [CrossRef]
  11. Mehlhorn, A.; Rahimi, P.; Joseph, Y. Aptamer-Based Biosensors for Antibiotic Detection: A Review. Biosensors 2018, 8, 54. [Google Scholar] [CrossRef] [PubMed]
  12. Alawad, A.; Istamboulié, G.; Calas-Blanchard, C.; Noguer, T. A Reagentless Aptasensor Based on Intrinsic Aptamer Redox Activity for the Detection of Tetracycline in Water. Sens. Actuators B: Chem. 2019, 288, 141–146. [Google Scholar] [CrossRef]
  13. Yu, H.; Alkhamis, O.; Canoura, J.; Liu, Y.; Xiao, Y. Advances and Challenges in Small-Molecule DNA Aptamer Isolation, Characterization, and Sensor Development. Angew. Chem. Int. Ed. Engl. 2021, 60, 16800–16823. [Google Scholar] [CrossRef]
  14. Alkhamis, O.; Canoura, J.; Yu, H.; Liu, Y.; Xiao, Y. Innovative Engineering and Sensing Strategies for Aptamer-Based Small-Molecule Detection. TrAC Trends Anal. Chem. 2019, 121, 115699. [Google Scholar] [CrossRef]
  15. Ruscito, A.; DeRosa, M.C. Small-Molecule Binding Aptamers: Selection Strategies, Characterization, and Applications. Front. Chem. 2016, 4, 14. [Google Scholar] [CrossRef]
  16. Wang, S.; Yan, X.; Yang, Y.; Qi, X.; Zhao, Y.; Li, L.; Ma, R.; Wang, L.; Dong, Y.; Sun, J.; et al. Advances and Perspectives of Aptasensors for the Detection of Tetracyclines: A Class of Model Compounds of Food Analysis. Food Chem. 2021, 364, 130361. [Google Scholar] [CrossRef]
  17. Nakatsuka, N.; Yang, K.-A.; Abendroth, J.M.; Cheung, K.M.; Xu, X.; Yang, H.; Zhao, C.; Zhu, B.; Rim, Y.S.; Yang, Y.; et al. Aptamer–Field-Effect Transistors Overcome Debye Length Limitations for Small-Molecule Sensing. Science 2018, 362, 319–324. [Google Scholar] [CrossRef]
  18. Yang, K.-A.; Chun, H.; Zhang, Y.; Pecic, S.; Nakatsuka, N.; Andrews, A.M.; Worgall, T.S.; Stojanovic, M.N. High-Affinity Nucleic-Acid-Based Receptors for Steroids. ACS Chem. Biol. 2017, 12, 3103–3112. [Google Scholar] [CrossRef]
  19. Yu, H.; Luo, Y.; Alkhamis, O.; Canoura, J.; Yu, B.; Xiao, Y. Isolation of Natural DNA Aptamers for Challenging Small-Molecule Targets, Cannabinoids. Anal. Chem. 2021, 93, 3172–3180. [Google Scholar] [CrossRef]
  20. Huang, P.-J.J.; Liu, J. Selection of Aptamers for Sensing Caffeine and Discrimination of Its Three Single Demethylated Analog. Anal. Chem. 2022, 94, 3142–3149. [Google Scholar] [CrossRef]
  21. Luo, Y.; Jin, Z.; Wang, J.; Ding, P.; Pei, R. The Isolation of a DNA Aptamer to Develop a Fluorescent Aptasensor for the Thiamethoxam Pesticide. Analyst 2021, 146, 1986–1995. [Google Scholar] [CrossRef] [PubMed]
  22. Tian, H.; Duan, N.; Wu, S.; Wang, Z. Selection and Application of Ssdna Aptamers against Spermine Based on Capture-Selex. Anal. Chim. Acta 2019, 1081, 168–175. [Google Scholar] [CrossRef]
  23. Zhao, Y.; Ong, S.; Chen, Y.; Jimmy Huang, P.-J.; Liu, J. Label-Free and Dye-Free Fluorescent Sensing of Tetracyclines Using a Capture-Selected DNA Aptamer. Anal. Chem. 2022, 94, 10175–10182. [Google Scholar] [CrossRef] [PubMed]
  24. Carlotti, B.; Fuoco, D.; Elisei, F. Fast and Ultrafast Spectroscopic Investigation of Tetracycline Derivatives in Organic and Aqueous Media. PCCP 2010, 12, 15580–15591. [Google Scholar] [CrossRef] [PubMed]
  25. Müller, M.; Weigand, J.E.; Weichenrieder, O.; Suess, B. Thermodynamic Characterization of an Engineered Tetracycline-Binding Riboswitch. Nucleic Acids Res. 2006, 34, 2607–2617. [Google Scholar] [CrossRef] [PubMed]
  26. Niazi, J.H.; Lee, S.J.; Kim, Y.S.; Gu, M.B. Ssdna Aptamers That Selectively Bind Oxytetracycline. Bioorg. Med. Chem. 2008, 16, 1254–1261. [Google Scholar] [CrossRef]
  27. Niazi, J.H.; Lee, S.J.; Gu, M.B. Single-Stranded DNA Aptamers Specific for Antibiotics Tetracyclines. Bioorg. Med. Chem. 2008, 16, 7245–7253. [Google Scholar] [CrossRef]
  28. Berens, C.; Thain, A.; Schroeder, R. A Tetracycline-Binding RNA Aptamer. Bioorg. Med. Chem. 2001, 9, 2549–2556. [Google Scholar] [CrossRef]
  29. Tickner, Z.J.; Zhong, G.; Sheptack, K.R.; Farzan, M. Selection of High-Affinity RNA Aptamers That Distinguish between Doxycycline and Tetracycline. Biochemistry 2020, 59, 3473–3486. [Google Scholar] [CrossRef]
  30. Jezowska-Bojczuk, M.; Lambs, L.; Kozlowski, H.; Berthon, G. Metal Ion-Tetracycline Interactions in Biological Fluids. 10. Structural Investigations on Copper(Ii) Complexes of Tetracycline, Oxytetracycline, Chlortetracycline, 4-(Dedimethylamino)Tetracycline, and 6-Desoxy-6-Demethyltetracycline and Discussion of Their Binding Modes. Inorg. Chem. 1993, 32, 428–437. [Google Scholar]
  31. Lambs, L.; Decock-Le Reverend, B.; Kozlowski, H.; Berthon, G. Metal Ion-Tetracycline Interactions in Biological Fluids. 9. Circular Dichroism Spectra of Calcium and Magnesium Complexes with Tetracycline, Oxytetracycline, Doxycycline, and Chlortetracycline and Discussion of Their Binding Modes. Inorg. Chem. 1988, 27, 3001–3012. [Google Scholar] [CrossRef]
  32. Lambs, L.; Brion, M.; Berthon, G. Metal Ion-Tetracycline Interactions in Biological Fluids. Part 3. Formation of Mixed-Metal Ternary Complexes of Tetracycline, Oxytetracycline, Doxycycline and Minocycline with Calcium and Magnesium, and Their Involvement in the Bioavailability of These Antibiotics in Blood Plasma. Agents Actions 1984, 14, 743–750. [Google Scholar] [PubMed]
  33. Schneider, S.; Schmitt, M.O.; Brehm, G.; Reiher, M.; Matousek, P.; Towrie, M. Fluorescence Kinetics of Aqueous Solutions of Tetracycline and Its Complexes with Mg2+ and Ca2+. Photochem. Photobiol. Sci. 2003, 2, 1107–1117. [Google Scholar] [CrossRef] [PubMed]
  34. Lorsch, J.R.; Szostak, J.W. In Vitro Selection of RNA Aptamers Specific for Cyanocobalamin. Biochemistry 1994, 33, 973–982. [Google Scholar] [CrossRef] [PubMed]
  35. Liu, Y.; Liu, J. Selection of DNA Aptamers for Sensing Uric Acid in Simulated Tears. Anal. Sens. 2022, 2, e202200010. [Google Scholar] [CrossRef]
  36. Li, Y.; Wang, H.; Liu, X.; Zhao, G.; Sun, Y. Dissipation Kinetics of Oxytetracycline, Tetracycline, and Chlortetracycline Residues in Soil. Environ. Sci. Pollut. Res. 2016, 23, 13822–13831. [Google Scholar] [CrossRef]
  37. Xuan, R.; Arisi, L.; Wang, Q.; Yates, S.R.; Biswas, K.C. Hydrolysis and Photolysis of Oxytetracycline in Aqueous Solution. J. Environ. Sci. Health B 2009, 45, 73–81. [Google Scholar] [CrossRef]
  38. Guerra, W.; Silva-Caldeira, P.P.; Terenzi, H.; Pereira-Maia, E.C. Impact of Metal Coordination on the Antibiotic and Non-Antibiotic Activities of Tetracycline-Based Drugs. Coord. Chem. Rev. 2016, 327–328, 188–199. [Google Scholar] [CrossRef]
  39. Li, Y.; Gao, H.; Qi, Z.; Huang, Z.; Ma, L.; Liu, J. Freezing-Assisted Conjugation of Unmodified Diblock DNA to Hydrogel Nanoparticles and Monoliths for DNA and Hg2+ Sensing. Angew. Chem. Int. Ed. 2021, 60, 12985–12991. [Google Scholar] [CrossRef]
  40. Ayodele, O.O.; Adesina, A.O.; Pourianejad, S.; Averitt, J.; Ignatova, T. Recent Advances in Nanomaterial-Based Aptasensors in Medical Diagnosis and Therapy. Nanomaterials 2021, 11, 932. [Google Scholar] [CrossRef]
Figure 1. The general structure of the tetracyclines with their respective pKa values. (A) pKa values and structures adapted from ref. [16,36]. (B) The structure of the tetracyclines at pH 6.0 and pH 8.3. (C) The secondary structure of the OTC5 aptamer. (D) A cartoon showing the fluorescence enhancement of the tetracyclines upon aptamer binding.
Figure 1. The general structure of the tetracyclines with their respective pKa values. (A) pKa values and structures adapted from ref. [16,36]. (B) The structure of the tetracyclines at pH 6.0 and pH 8.3. (C) The secondary structure of the OTC5 aptamer. (D) A cartoon showing the fluorescence enhancement of the tetracyclines upon aptamer binding.
Biosensors 12 00717 g001
Figure 2. The fluorescence intensity at 530 nm of the tetracycline antibiotics at pH 6.0 and pH 8.3 in the presence of increasing concentration of Mg2+: (A) DOX, (B) OTC, and (C) TC.
Figure 2. The fluorescence intensity at 530 nm of the tetracycline antibiotics at pH 6.0 and pH 8.3 in the presence of increasing concentration of Mg2+: (A) DOX, (B) OTC, and (C) TC.
Biosensors 12 00717 g002
Figure 3. (A) Fluorescence spectra of 100 nM OTC in the absence and presence of 2 µM OTC5 aptamer at pH 6.0. (B) pH-dependent fluorescence of 1 µM OTC in the absence and presence of 2 µM OTC5 aptamer. pH 4 and 5: acetate buffer; pH 6 and 7: phosphate buffer; pH 8: Tris buffer. All with 10 mM Mg2+. (C) The fold of fluorescence enhancement at different pH levels due to the addition of the OTC5 aptamer.
Figure 3. (A) Fluorescence spectra of 100 nM OTC in the absence and presence of 2 µM OTC5 aptamer at pH 6.0. (B) pH-dependent fluorescence of 1 µM OTC in the absence and presence of 2 µM OTC5 aptamer. pH 4 and 5: acetate buffer; pH 6 and 7: phosphate buffer; pH 8: Tris buffer. All with 10 mM Mg2+. (C) The fold of fluorescence enhancement at different pH levels due to the addition of the OTC5 aptamer.
Biosensors 12 00717 g003
Figure 4. Aptamer binding curves for (A,B) DOX, (C,D) OTC, and (E,F) TC in (A,C,E) pH 6.0 buffer and (B,D,F) pH 8.3 buffers in the absence or presence of 2 mM Mg2+.
Figure 4. Aptamer binding curves for (A,B) DOX, (C,D) OTC, and (E,F) TC in (A,C,E) pH 6.0 buffer and (B,D,F) pH 8.3 buffers in the absence or presence of 2 mM Mg2+.
Biosensors 12 00717 g004
Figure 5. ITC traces of 150 μM OTC titrated into 9 μM OTC5 at (A) pH 6.0 and (B) pH 8.3. Both samples contained 2 mM Mg2+.
Figure 5. ITC traces of 150 μM OTC titrated into 9 μM OTC5 at (A) pH 6.0 and (B) pH 8.3. Both samples contained 2 mM Mg2+.
Biosensors 12 00717 g005
Figure 6. The fluorescence of 100 nM OTC alone and with 2 µM OTC5 aptamer as a function of (A) Ca2+, (B) Mn2+, and (C) Zn2+ concentration. All the experiments were run in pH 6.0 MES buffer.
Figure 6. The fluorescence of 100 nM OTC alone and with 2 µM OTC5 aptamer as a function of (A) Ca2+, (B) Mn2+, and (C) Zn2+ concentration. All the experiments were run in pH 6.0 MES buffer.
Biosensors 12 00717 g006
Figure 7. Fluorescence intensity of (A) DOX, (B) OTC, and (C) TC in the absence (black dots) and presence (red dots) of 2 µM OTC5 aptamer. Fluorescence difference of (D) DOX, (E) OTC, and (F) TC in the presence and absence of 2 µM OTC5 aptamer. The measurements were performed in pH 6 buffer with 2 mM Mg2+.
Figure 7. Fluorescence intensity of (A) DOX, (B) OTC, and (C) TC in the absence (black dots) and presence (red dots) of 2 µM OTC5 aptamer. Fluorescence difference of (D) DOX, (E) OTC, and (F) TC in the presence and absence of 2 µM OTC5 aptamer. The measurements were performed in pH 6 buffer with 2 mM Mg2+.
Biosensors 12 00717 g007
Figure 8. Selectivity of the OTC5 aptamer in (A) pH 6.0 MES buffer and (B) pH 8.3 Tris buffer, each with 2 mM Mg2+. An amount of 2 µM of OTC5 was added to 100 nM of antibiotic. Samples were scanned at an excitation wavelength of 370 nm and emission of 530 nm. (C) The fluorescence difference at pH 6.0 and 8.3 with and without OTC5. STR: streptomycin; PEN: penicillin; AMP: ampicillin; KAN: kanamycin.
Figure 8. Selectivity of the OTC5 aptamer in (A) pH 6.0 MES buffer and (B) pH 8.3 Tris buffer, each with 2 mM Mg2+. An amount of 2 µM of OTC5 was added to 100 nM of antibiotic. Samples were scanned at an excitation wavelength of 370 nm and emission of 530 nm. (C) The fluorescence difference at pH 6.0 and 8.3 with and without OTC5. STR: streptomycin; PEN: penicillin; AMP: ampicillin; KAN: kanamycin.
Biosensors 12 00717 g008
Figure 9. (A) Fluorescence intensity as a function of OTC concentration in spiked milk samples after extraction without and with 2 μM OTC5 aptamer at pH 6.0 with 2 mM Mg2+. (B) Fluorescence difference of the two curves in (A) as a function of OTC concentration at pH 6.0.
Figure 9. (A) Fluorescence intensity as a function of OTC concentration in spiked milk samples after extraction without and with 2 μM OTC5 aptamer at pH 6.0 with 2 mM Mg2+. (B) Fluorescence difference of the two curves in (A) as a function of OTC concentration at pH 6.0.
Biosensors 12 00717 g009
Table 1. Thermodynamic values of the aptamers based on ITC a.
Table 1. Thermodynamic values of the aptamers based on ITC a.
AptamerTargetpHNKD (μM)ΔH (cal/mol) (×104)ΔS (cal/mol/K)
OTC5OTC6.00.920.2−2.89−66.3
OTC5OTC8.31.270.03−1.99−32.6
a Binding ratio (N), dissociation constant (KD), enthalpy change (ΔH), and entropy change (ΔS) of the binding reactions are supplied.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Zhao, Y.; Gao, B.; Sun, P.; Liu, J.; Liu, J. Metal and pH-Dependent Aptamer Binding of Tetracyclines Enabling Highly Sensitive Fluorescence Sensing. Biosensors 2022, 12, 717. https://doi.org/10.3390/bios12090717

AMA Style

Zhao Y, Gao B, Sun P, Liu J, Liu J. Metal and pH-Dependent Aptamer Binding of Tetracyclines Enabling Highly Sensitive Fluorescence Sensing. Biosensors. 2022; 12(9):717. https://doi.org/10.3390/bios12090717

Chicago/Turabian Style

Zhao, Yichen, Biwen Gao, Peihuan Sun, Jiawen Liu, and Juewen Liu. 2022. "Metal and pH-Dependent Aptamer Binding of Tetracyclines Enabling Highly Sensitive Fluorescence Sensing" Biosensors 12, no. 9: 717. https://doi.org/10.3390/bios12090717

APA Style

Zhao, Y., Gao, B., Sun, P., Liu, J., & Liu, J. (2022). Metal and pH-Dependent Aptamer Binding of Tetracyclines Enabling Highly Sensitive Fluorescence Sensing. Biosensors, 12(9), 717. https://doi.org/10.3390/bios12090717

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop